<DOC>
	<DOCNO>NCT00092482</DOCNO>
	<brief_summary>The purpose study determine investigational vaccine single component develop immune response similar equivalent investigational vaccine four component reduce cervical disease .</brief_summary>
	<brief_title>Immunogenicity Bridge Between Investigational Monovalent Vaccine Equivalent Component Gardasil ( V501 ) Quadrivalent Vaccine ( V501-012 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Female intact uterus lifetime history 04 sexual partner Prior Human Papillomavirus Vaccine ( HPV ) vaccination ; Prior abnormal pap ; Prior history genital wart</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>